Rheumatoid Arthritis-API Insights , 2017 The active pharmaceutical ingredients worldwide market is in continuous development from the recent years . There is expected to be a major impact on the global API industry , with the large number of blockbuster drugs going off patent in the coming years . It is going to affect the revenue of the API market as generic drugs occupy the market .
Rheumatoid Arthritis-API Insights , 2017 The active pharmaceutical ingredients worldwide market is in continuous development from the recent years . There is expected to be a major impact on the global API industry , with the large number of blockbuster drugs going off patent in the coming years . It is going to affect the revenue of the API market as generic drugs occupy the market .
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently . The USFDA and EMA have strict guidelines for API manufacturing ' Process Validation : General Principles and Practices '. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation , India and China follow their national GMP guidelines . The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain , with a vast majority of the APIs and intermediates being sourced from markets such as India and China .
Rheumatoid Arthritis -API Insights , 2017 Report describes the current therapeutics that is propelling the pharmaceutical markets worldwide . The report gives the clear idea on the United States Drug Master File ( USDMF ) and Europe DMF filed by worldwide countries related to the Rheumatoid Arthritis . It also provides the India and China API Manufactures who are driving the current API Market . The report also highlights the patent and patent exclusivity information . The research analysis also presents the global sales data till 2016 . Data Sources